These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31288553)

  • 1. NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?
    Yilmaz Y; Eren F
    Angiology; 2020 Jan; 71(1):83-84. PubMed ID: 31288553
    [No Abstract]   [Full Text] [Related]  

  • 2. The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease.
    Turan Y
    Angiology; 2020 Jan; 71(1):77-82. PubMed ID: 31018673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply to the Letter to the Editor Entitled "NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?".
    Turan Y; Demir V; Turan E; Hidayet Ş
    Angiology; 2020 Jan; 71(1):85-86. PubMed ID: 31450946
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.
    Dogan S; Celikbilek M; Yilmaz YK; Sarikaya S; Zararsiz G; Serin HI; Borekci E; Akyol L; Pirti I; Davarci SE
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):298-304. PubMed ID: 25629574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
    Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
    Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
    Tapper EB; Hunink MG; Afdhal NH; Lai M; Sengupta N
    PLoS One; 2016; 11(2):e0147237. PubMed ID: 26905872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography.
    Tapper EB; Sengupta N; Hunink MG; Afdhal NH; Lai M
    Am J Gastroenterol; 2015 Sep; 110(9):1298-304. PubMed ID: 26303130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease.
    Lee SH; Yun SJ; Kim DH; Jo HH; Park YS
    J Clin Ultrasound; 2017 Sep; 45(7):391-399. PubMed ID: 28369989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.
    Simon TG; Corey KE; Cannon CP; Blazing M; Park JG; O'Donoghue ML; Chung RT; Giugliano RP
    Int J Cardiol; 2018 Nov; 270():245-252. PubMed ID: 29903515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.
    Petta S; Vanni E; Bugianesi E; Di Marco V; Cammà C; Cabibi D; Mezzabotta L; Craxì A
    Liver Int; 2015 May; 35(5):1566-73. PubMed ID: 24798049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.
    Yayla Ç; Yayla KG; Karanfil M; Ertem AG; Ünal S; Erdöl MA; Demirtaş K; Akdi A; Çöteli C; Özilhan MO; Karaaslan ÖÇ
    Angiology; 2020 Jan; 71(1):87. PubMed ID: 31319680
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：.
    Idilman IS; Akata D; Hazirolan T; Doganay Erdogan B; Aytemir K; Karcaaltincaba M
    J Diabetes; 2015 Mar; 7(2):279-86. PubMed ID: 24893617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.
    Patel SS; Nabi E; Guzman L; Abbate A; Bhati C; Stravitz RT; Reichman T; Matherly SC; Driscoll C; Lee H; Luketic VA; Sterling RK; Sanyal AJ; Patel V; Levy M; Siddiqui MS
    Liver Transpl; 2018 Mar; 24(3):333-342. PubMed ID: 29328556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey.
    Hartleb M; Barański K; Zejda J; Chudek J; Więcek A
    Liver Int; 2017 Nov; 37(11):1706-1714. PubMed ID: 28489307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte extracellular vesicle concentration is inversely associated with liver fibrosis severity in NAFLD.
    Welsh JA; Scorletti E; Clough GF; Englyst NA; Byrne CD
    J Leukoc Biol; 2018 Sep; 104(3):631-639. PubMed ID: 29603349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between nonalcoholic fatty liver disease and coronary artery disease.
    Vilar CP; Cotrim HP; Florentino GS; Barreto CP; Florentino AV; Bragagnoli G; Schwingel PA
    Rev Assoc Med Bras (1992); 2013; 59(3):290-7. PubMed ID: 23684211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area.
    Vilar CP; Cotrim HP; Florentino GS; Bragagnoli G; Schwingel PA; Barreto CP
    Arq Gastroenterol; 2015; 52(2):111-6. PubMed ID: 26039828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.
    Friedrich-Rust M; Schoelzel F; Maier S; Seeger F; Rey J; Fichtlscherer S; Herrmann E; Zeuzem S; Bojunga J
    PLoS One; 2017; 12(10):e0186720. PubMed ID: 29073252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.